首页> 美国卫生研究院文献>Canadian Journal of Comparative Medicine >Adequacy of commercial lentogenic vaccines against Canadian strains of viscerotropic Newcastle disease virus.
【2h】

Adequacy of commercial lentogenic vaccines against Canadian strains of viscerotropic Newcastle disease virus.

机译:针对加拿大内脏新城疫病毒加拿大株的商业化的慢病毒疫苗是否足够。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Three field strains of Newcastle Disease virus, designated S20, S21 and S23, isolated from chickens or turkeys in Ontario during the 1971-72 epizootic, were characterized as velogenic viscerotropic viruses. No significant antigenic differences were demonstrated among B1, LaSota and a field strain (S23) of velogenic vescerotropic virus by haemagglutination inhibition or protection tests. Primary water vaccination of chicks with commercial B1 and LaSota vaccines at five weeks of age and aerosol revaccination with the same strains four weeks later resulted in protection that lasted 16 weeks after revaccination against experimental challenge with strain S23. The differences in haemagglutination inhibition titres noted when the homologous or the heterologous viruses were used as haemagglutinating antigen were not statistically significant. The rates of decay of virus neutralizing and haemagglutination inhibition antibodies in vaccinated birds showed a divergence indicating the possible duality of antibodies measured in serum neutralization and haemagglutination inhibition tests.
机译:在1971-72年流行期间从安大略省的鸡或火鸡中分离出的三个新城疫病毒野外毒株,分别命名为S20,S21和S23,被定为速溶型内变病毒。通过血细胞凝集抑制或保护试验,在B1,LaSota和velos嗜多型性病毒的野毒株(S23)之间未发现明显的抗原差异。在五周龄时用商品化的B1和LaSota疫苗对雏鸡进行初次水疫苗接种,并在四周后对同一菌株进行气雾剂再免疫,从而在疫苗接种后抵抗抗S23菌株的实验持续了16周。当同源或异源病毒用作血凝抗原时,血凝抑制效价的差异无统计学意义。疫苗中禽中病毒中和和血凝抑制抗体的衰减速率显示出差异,表明在血清中和和血凝抑制试验中测得的抗体可能具有双重性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号